First Clinical Results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma.

MLA

Burger, Irene A., et al. “First Clinical Results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma.” Journal of Nuclear Medicine, vol. 55, no. 11, Nov. 2014, pp. 1778–85. EBSCOhost, https://doi.org/10.2967/jnumed.114.140699.

APA

Burger, I. A., Zitzmann-Kolbe, S., Pruim, J., Friebe, M., Graham, K., Stephens, A., Dinkelborg, L., Kowal, K., Schibli, R., Luurtsema, G., Maas, B., Horn-Tutic, M., Haerle, S. K., Wiegers, J., Schaefer, N. G., Hany, T. F., & von Schulthess, G. K. (2014). First Clinical Results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma. Journal of Nuclear Medicine, 55(11), 1778–1785. https://doi.org/10.2967/jnumed.114.140699

Chicago

Burger, Irene A., Sabine Zitzmann-Kolbe, Jan Pruim, Matthias Friebe, Keith Graham, Andrew Stephens, Ludger Dinkelborg, et al. 2014. “First Clinical Results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma.” Journal of Nuclear Medicine 55 (11): 1778–85. doi:10.2967/jnumed.114.140699.